Legence Announces Pricing of Upsized Secondary Underwritten Public Offering of Class A Common Stock

Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced the pricing of an upsized secondary underwritten ...

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the ...